Viewing Study NCT01973660


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2026-05-24 @ 12:10 PM
Study NCT ID: NCT01973660
Status: COMPLETED
Last Update Posted: 2018-09-19
First Post: 2013-10-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: PAM50 HER2-enriched Phenotype as a Predictor of Response to Dual HER2 Blockade in HER2-positive Early Breast Cancer
Sponsor: SOLTI Breast Cancer Research Group
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Human Epidermal Growth Factor Receptor 2 View
None HER2 View
None HER2 positive View
None PAM50 View
None lapatinib View
None trastuzumab View
None dual HER2 blockade View
None neoadjuvant View